Sector portfolio · Venture debt · United States

Hercules Capital's Biotech portfolio

Hercules Capital has backed 20 Biotech startups in rounds we track, $2.7B between them, shown by the stage each has reached. The best-funded is Dyne Therapeutics.

20startups backed
3stages
$2.7Braised between them
Stage not reportedbiggest stage

Hercules Capital's whole portfolioHercules Capital's profile

Segment by segment

Stage not reported

11 startups · $1.9B raised

  1. Phathom PharmaceuticalsPhathom Pharmaceuticals is a biopharmaceutical company.United States$530M
  2. 4D Molecular Therapeutics4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.United States$307M
  3. MoonLake ImmunotherapeuticsMoonLake Immunotherapeutics is a clinical-stage biopharmaceuticals company.Switzerland$275M
  4. X4 PharmaceuticalsX4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.United States$193M
  5. Replimune GroupReplimune Group develop the next generation of ‘oncolytic immunotherapies’ for the treatment of cancer.United States$140M
  6. Aprecia PharmaceuticalsAprecia Pharmaceuticals develops precision drug delivery systems and products.United States$123M
  7. SSebaciaSebacia is a commercial-stage dermatology company that develops an alternative to the topical and systemic drugs for the treatment of acne.United States$102M
  8. EloxxEloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates.United States$66M

Series B

5 startups · $338M raised

  1. Lucira HealthLucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.United States$95M
  2. SynOx TherapeuticsSynOx Therapeutics is a late-stage clinical biopharmaceutical company based in Dublin, Ireland.Ireland$92M
  3. Provention BioProvention Bio is a clinical stage biopharmaceutical dedicated to sourcing, developing, and commercializing novel therapeutics.United States$63M
  4. Locus BiosciencesLocus Biosciences develops CRISPR-engineered precision antibacterial platform designed to revolutionize the treatment of bacterial disease.United States$54M
  5. Gamma MedicaGamma Medica offers LumaGEM® MBI System, an FDA-cleared dual-headed digital imaging system.United States$34M

Series C and later

4 startups · $505M raised

  1. MedroboticsMedrobotics is a medical robotics company developing and commercializing the Flex Robotic System.United States$176M
  2. 908 Devices908devices manufactures battery-operated, hand-held chemical detection tools used in mass spectrometry.United States$168M
  3. NorthSea TherapeuticsNorthSea Therapeutics B.V.Netherlands$109M
  4. Sight SciencesSight Sciences is a medical device company that uses a computer-based device designed for the treatment of eye disease.United States$52M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Hercules Capital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios

Raising from investors like Hercules Capital?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.